Lipid Peroxidation and Its Toxicological Implications

Overview

Journal Toxicol Res

Specialty Toxicology

Date 2013 Nov 27

PMID 24278542

Citations 34

Authors

Tae-Gyu Nam

Affiliations

Soon will be listed here.

Abstract

Lipid peroxidation is a free radical oxidation of polyunsaturated fatty acids such as linoleic acid or arachidonic acid. This process has been related with various pathologies and disease status mainly because of the oxidation products formed during the process. The oxidation products include reactive aldehydes such as malondialdehyde and 4-hydroxynonenal. These reactive aldehydes can form adducts with DNAs and proteins, leading to the alterations in their functions to cause various diseases. This review will provide a short summary on the implication of lipid peroxidation on cancer, atherosclerosis, and neurodegeneration as well as chemical and biochemical mechanisms by which these adducts affect the pathological conditions. In addition, select examples will be presented where antioxidants were used to counteract oxidative damage caused by lipid peroxidation. At the end, isoprostanes are discussed as a gold standard for the assessment of oxidative damages.

Citing Articles

Role of Leaf Phytosomes Against Oxidative Stress and Inflammation in Rats Fed with a High-Fat-Fructose Diet.

Ortega-Perez L, Hernandez-Soto J, Padilla-Avalos O, Ayala-Ruiz L, Magana-Rodriguez O, Pinon-Simental J Antioxidants (Basel). 2024; 13(10).

PMID: 39456515 PMC: 11504497. DOI: 10.3390/antiox13101263.

The use of vitamin E in ocular health: Bridging omics approaches with Tocopherol and Tocotrienol in the management of glaucoma.

Latib F, Zafendi M, Lazaldin M Food Chem (Oxf). 2024; 9:100224.

PMID: 39415777 PMC: 11481750. DOI: 10.1016/j.fochms.2024.100224.

Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.

Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomolecules. 2024; 14(9).

PMID: 39334822 PMC: 11430732. DOI: 10.3390/biom14091055.

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review.

Baeza-Morales A, Medina-Garcia M, Martinez-Peinado P, Pascual-Garcia S, Pujalte-Satorre C, Lopez-Jaen A Antioxidants (Basel). 2024; 13(9).

PMID: 39334719 PMC: 11428676. DOI: 10.3390/antiox13091060.

Medicinal evaluation and molecular docking study of osajin as an anti-inflammatory, antioxidant, and antiapoptotic agent against sepsis-associated acute kidney injury in rats.

Alhilal M, Erol H, Yildirim S, Cakir A, Koc M, Alhilal S Ren Fail. 2024; 46(2):2379008.

PMID: 39034431 PMC: 11262233. DOI: 10.1080/0886022X.2024.2379008.

References

Adams Jr J, Odunze I . Oxygen free radicals and Parkinson's disease. Free Radic Biol Med. 1991; 10(2):161-9. DOI: 10.1016/0891-5849(91)90009-r. View

Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman E, Mizuno Y . Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A. 1996; 93(7):2696-701. PMC: 39693. DOI: 10.1073/pnas.93.7.2696. View

Bradley M, Markesbery W, Lovell M . Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med. 2010; 48(12):1570-6. PMC: 2881698. DOI: 10.1016/j.freeradbiomed.2010.02.016. View

Drake J, Petroze R, Castegna A, Ding Q, Keller J, Markesbery W . 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neurosci Lett. 2004; 356(3):155-8. DOI: 10.1016/j.neulet.2003.11.047. View

Kim H, Pratt D, Seal J, Wijtmans M, Porter N . Lipid-soluble 3-pyridinol antioxidants spare alpha-tocopherol and do not efficiently mediate peroxidation of cholesterol esters in human low-density lipoprotein. J Med Chem. 2005; 48(22):6787-9. DOI: 10.1021/jm0507173. View

Lovell M, Ehmann W, Mattson M, Markesbery W . Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging. 1997; 18(5):457-61. DOI: 10.1016/s0197-4580(97)00108-5. View

Rouzer C, Marnett L . Cyclooxygenases: structural and functional insights. J Lipid Res. 2008; 50 Suppl:S29-34. PMC: 2674713. DOI: 10.1194/jlr.R800042-JLR200. View

Porter N, Caldwell S, Mills K . Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 1995; 30(4):277-90. DOI: 10.1007/BF02536034. View

Minko I, Kozekov I, Harris T, Rizzo C, Lloyd R, Stone M . Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem Res Toxicol. 2009; 22(5):759-78. PMC: 2685875. DOI: 10.1021/tx9000489. View

10.

Lovell M, Xie C, Markesbery W . Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging. 2001; 22(2):187-94. DOI: 10.1016/s0197-4580(00)00235-9. View

11.

Morrow J, Hill K, Burk R, Nammour T, Badr K, Roberts 2nd L . A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990; 87(23):9383-7. PMC: 55169. DOI: 10.1073/pnas.87.23.9383. View

12.

Muller F, Lustgarten M, Jang Y, Richardson A, Van Remmen H . Trends in oxidative aging theories. Free Radic Biol Med. 2007; 43(4):477-503. DOI: 10.1016/j.freeradbiomed.2007.03.034. View

13.

Chaudhary A, Reddy G, Blair I, Marnett L . Characterization of an N6-oxopropenyl-2'-deoxyadenosine adduct in malondialdehyde-modified DNA using liquid chromatography/electrospray ionization tandem mass spectrometry. Carcinogenesis. 1996; 17(5):1167-70. DOI: 10.1093/carcin/17.5.1167. View

14.

Roberts 2nd L, Oates J, Linton M, Fazio S, Meador B, Gross M . The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007; 43(10):1388-93. PMC: 2072864. DOI: 10.1016/j.freeradbiomed.2007.06.019. View

15.

Milne G, Yin H, Morrow J . Human biochemistry of the isoprostane pathway. J Biol Chem. 2008; 283(23):15533-7. PMC: 2414280. DOI: 10.1074/jbc.R700047200. View

16.

Morrow J . Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol. 2004; 25(2):279-86. DOI: 10.1161/01.ATV.0000152605.64964.c0. View

17.

Morrow J, Frei B, Longmire A, Gaziano J, Lynch S, Shyr Y . Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995; 332(18):1198-203. DOI: 10.1056/NEJM199505043321804. View

18.

Roberts 2nd L, Montine T, Markesbery W, Tapper A, Hardy P, Chemtob S . Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998; 273(22):13605-12. DOI: 10.1074/jbc.273.22.13605. View

19.

Ji C, Kozak K, Marnett L . IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J Biol Chem. 2001; 276(21):18223-8. DOI: 10.1074/jbc.M101266200. View

20.

Davies S, Roberts 2nd L . F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med. 2010; 50(5):559-66. PMC: 3058898. DOI: 10.1016/j.freeradbiomed.2010.11.023. View